Advertisement

Topics

Optimer Raises $77.6M, Former Sequenom Patent Agent Pleads Guilty, IPO Lineup Includes San Diego’s Ambit and IASO Pharma, & More San Diego Life Sciences News

04:40 EST 17 Feb 2011 |

With San Diego’s Optimer and Conatus Pharmaceuticals successfully raising capital, and Sanderling Ventures reportedly planning to raise a new fund, it would be easy to think that the capital markets are opening a little for the life sciences sector. You decide. —San Diego’s Optimer Pharmaceuticals (NASDAQ: OPTR) completed a secondary public offering of 7.8 million [...]

Original Article: Optimer Raises $77.6M, Former Sequenom Patent Agent Pleads Guilty, IPO Lineup Includes San Diego’s Ambit and IASO Pharma, & More San Diego Life Sciences News

NEXT ARTICLE

More From BioPortfolio on "Optimer Raises $77.6M, Former Sequenom Patent Agent Pleads Guilty, IPO Lineup Includes San Diego’s Ambit and IASO Pharma, & More San Diego Life Sciences News"

Advertisement
Quick Search
Advertisement
Advertisement